左金加味方联合针灸治疗肝胃郁热型胃食管反流病的疗效及对脑肠肽的影响研究

徐致君, 杨振斌, 邱伟, 夏文娟, 陈莉丽

徐致君, 杨振斌, 邱伟, 夏文娟, 陈莉丽. 左金加味方联合针灸治疗肝胃郁热型胃食管反流病的疗效及对脑肠肽的影响研究[J]. 实用临床医药杂志, 2024, 28(5): 63-67. DOI: 10.7619/jcmp.20233716
引用本文: 徐致君, 杨振斌, 邱伟, 夏文娟, 陈莉丽. 左金加味方联合针灸治疗肝胃郁热型胃食管反流病的疗效及对脑肠肽的影响研究[J]. 实用临床医药杂志, 2024, 28(5): 63-67. DOI: 10.7619/jcmp.20233716
XU Zhijun, YANG Zhenbin, QIU Wei, XIA Wenjuan, CHEN Lili. Effect of Zuojin Jiawei Formula combined with acupuncture and moxibustion in treating gastroesophageal reflux disease of liver-stomach stagnation heat type and its impact on brain-gut peptides[J]. Journal of Clinical Medicine in Practice, 2024, 28(5): 63-67. DOI: 10.7619/jcmp.20233716
Citation: XU Zhijun, YANG Zhenbin, QIU Wei, XIA Wenjuan, CHEN Lili. Effect of Zuojin Jiawei Formula combined with acupuncture and moxibustion in treating gastroesophageal reflux disease of liver-stomach stagnation heat type and its impact on brain-gut peptides[J]. Journal of Clinical Medicine in Practice, 2024, 28(5): 63-67. DOI: 10.7619/jcmp.20233716

左金加味方联合针灸治疗肝胃郁热型胃食管反流病的疗效及对脑肠肽的影响研究

基金项目: 

江苏省中医药管理局项目 YB201971

详细信息
    通讯作者:

    陈莉丽, E-mail: sbyy_cll@163.com

  • 中图分类号: R241;R749.053;R573

Effect of Zuojin Jiawei Formula combined with acupuncture and moxibustion in treating gastroesophageal reflux disease of liver-stomach stagnation heat type and its impact on brain-gut peptides

  • 摘要:
    目的 

    探讨左金加味方联合针灸治疗肝胃郁热型胃食管反流病的疗效及对脑肠肽的影响。

    方法 

    选取2021年7月—2022年12月在扬州市中医院脾胃科门诊诊治的160例胃郁热型胃食管反流病患者为研究对象,随机分为西药组、中药组、针刺组、中药结合针刺组,每组40例。西药组以雷贝拉唑为主进行治疗,中药组单用左金加味方治疗,中药结合针刺组在左金加味方基础上予以针灸足三里、中脘、太冲、内关治疗,针刺组予以单纯针灸足三里、中脘、太冲、内关。4组均治疗8周,比较4组临床疗效、治疗前后耐信量表评分、中医主要症状积分、食管黏膜评分、血管活性肠肽水平。

    结果 

    治疗后,中药结合针刺组治疗总有效率高于其他3组,中医主要症状积分、耐信量表评分、食管黏膜评分、血浆血管活性肠肽水平低于其他3组和治疗前,差异有统计学意义(P < 0.05)。

    结论 

    左金加味方联合针灸可有效减轻胃食管反流病临床症状,促进黏膜愈合,提高治疗效果。

    Abstract:
    Objective 

    To investigate the therapeutic effect of Zuojin Jiawei Formula combined with acupuncture and moxibustion in gastroesophageal reflux disease (GERD) of liver-stomach stagnation heat type and its impact on brain-gut peptides.

    Methods 

    A total of 160 patients with GERD of liver-stomach stagnation heat type who were diagnosed and treated at the outpatient department of spleen and stomach of Yangzhou Hospital of Traditional Chinese Medicine from July 2021 to December 2022 were randomly divided into four groups: western medicine group, traditional Chinese medicine group, acupuncture group, and traditional Chinese medicine combined with acupuncture group, with 40 patients in each group. The western medicine group was treated with rabeprazole as the main drug, the traditional Chinese medicine group was treated with Zuojin Jiawei Formula alone, the traditional Chinese medicine combined with acupuncture group was treated with acupuncture at Zusanli, Zhongwan, Taichong, and Neiguan on the basis of Zuojin Jiawei Formula, and the acupuncture group was treated with acupuncture at Zusanli, Zhongwan, Taichong, and Neiguan alone. All four groups were treated for 8 weeks, and the clinical efficacy along with Reflux Disease Questionnaire score, main symptoms score of traditional Chinese medicine, esophageal mucosa score, and vasoactive intestinal peptide level before and after treatment were compared among the four groups.

    Results 

    After treatment, the total effective rate of the traditional Chinese medicine combined with acupuncture group was higher than the other three groups, and the scores of main symptoms of traditional Chinese medicine, Reflux Disease Questionnaire score, esophageal mucosa score, and plasma vasoactive intestinal peptide levels were lower than the other three groups and before treatment(P < 0.05).

    Conclusion 

    Zuojin Jiawei Formula combined with acupuncture can effectively alleviate the clinical symptoms of GERD, promote mucosal healing, and improve treatment outcomes.

  • 表  1   4组肝胃郁热型GERD患者临床疗效比较[n(%)]

    组别 n 临床治愈 显效 有效 无效 总有效
    西药组 40 12(30.00) 11(27.50) 9(22.50) 10(25.00) 30(75.00)*
    中药组 40 15(37.50) 10(25.00) 9(22.50) 6(15.00) 34(85.00)*
    针刺组 40 14(35.00) 11(27.50) 8(20.00) 7(17.50) 33(82.50)*
    中药结合针刺组 40 18(45.00) 12(30.00) 8(20.00) 2(5.00) 38(95.00)
    与中药结合针刺组比较, * P < 0.05。
    下载: 导出CSV

    表  2   4组肝胃郁热型GERD患者治疗前后耐信量表评分比较(x±s)  

    组别 n 治疗前 治疗后
    西药组 40 25.55±8.50 15.02±4.12*#
    中药组 40 26.16±7.04 11.25±9.19*#
    针刺组 40 25.28±8.25 14.25±9.19*#
    中药结合针刺组 40 26.86±9.38 5.08±2.03*
    与治疗前比较, * P < 0.05; 与中药结合针刺组比较, #P < 0.05。
    下载: 导出CSV

    表  3   4组肝胃郁热型GERD患者治疗前后中医症状评分比较(x±s)  

    组别 n 治疗前 治疗后
    西药组 40 12.44±3.28 5.86±3.08*#
    中药组 40 12.86±4.12 4.99±3.02*#
    针刺组 40 12.45±3.45 5.88±2.52*#
    中药结合针刺组 40 13.34±3.68 2.58±1.54*
    与治疗前比较, * P < 0.05; 与中药结合针刺组比较, #P < 0.05。
    下载: 导出CSV

    表  4   4组肝胃郁热型GERD患者治疗前后内镜下食管黏膜评分比较(x±s)  

    组别 n 治疗前 治疗后
    西药组 40 2.68±0.71 1.92±1.21*#
    中药组 40 2.58±0.81 1.80±1.34*#
    针刺组 40 2.72±0.83 1.78±1.34*#
    中药结合针刺组 40 2.76±0.80 0.83±0.55*
    与治疗前比较, * P < 0.05; 与中药结合针刺组比较, #P < 0.05。
    下载: 导出CSV

    表  5   4组肝胃郁热型GERD患者治疗前后血浆血管活性肠肽比较(x±s)  ng/L

    组别 n 治疗前 治疗后
    西药组 40 983.40±506.26 426.24±268.38*#
    中药组 40 968.25±489.48 555.90±321.02*#
    针刺组 40 980.26±467.52 486.25±276.06*#
    中药结合针刺组 40 898.25±499.52 206.25±102.24*
    与治疗前比较, * P < 0.05; 与中药结合针刺组比较, #P < 0.05。
    下载: 导出CSV
  • [1] 陈利嫒, 王佳, 侯奕同. 胃食管反流病治疗的研究进展[J]. 国际消化病杂志, 2020, 40(4): 215-218. https://www.cnki.com.cn/Article/CJFDTOTAL-GWXH202004002.htm
    [2] 中华中医药学会脾胃病分会. 胃食管反流病中医诊疗专家共识意见(2017)[J]. 中国中西医结合消化杂志. 2017, 25(5): 321-326. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ201911003.htm
    [3] 中华医学会消化病学分会. 2020年中国胃食管反流病专家共识[J]. 中华消化杂志, 2020, 40(10): 649-663. doi: 10.3760/cma.j.cn311367-20200918-00558
    [4] 石瑞春, 杨志伟, 陈永贵, 等. 采用耐信量表临床诊断胃食反流病(GERD)的可行性探讨[J]. 医药前沿, 2012(35): 19-20. doi: 10.3969/j.issn.2095-1752.2012.35.016
    [5] 郑筱萸. 中药新药临床研究指导原则[S]. 北京: 中国医药科技出版社, 2002: 135-136.
    [6] 赵晓晓, 谢佳平, 赵景润, 等. 复发性反流性食管炎内镜特征的临床对比研究[J]. 中华消化内镜杂志, 2020, 37(1): 45-47. doi: 10.3760/cma.j.issn.1007-5232.2020.01.010
    [7] 梁笑楠, 战蓉蓉, 张晓岚. 《2020年中国胃食管反流病专家共识》解读[J]. 河北医科大学学报, 2021, 42(8): 869-871. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYX202108002.htm
    [8] 杜明慧. 利用数据库分析胃食管反流病的发病因素与临床特点[J]. 现代医学与健康研究电子杂志, 2018, 2(10): 42-42.
    [9] 贾宁, 唐艳萍, 李杨. 现代医学对胃食管反流病研究机制进展[J]. 中国中西医结合外科杂志, 2020, 26(1): 179-183. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZX202001047.htm
    [10] 周玉军, 何凤芝. 对比雷贝拉唑与雷尼替丁在非糜烂性胃食管反流病中的疗效[J]. 中国实用医药, 2021, 16(3): 170-172. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSSA202136063.htm
    [11]

    YU LY, SUN LN, ZHANG XH, et al. A review of the novel application and potential adverse effects of proton pump inhibitors[J]. Adv Ther, 2017, 34(5): 1070-1086. doi: 10.1007/s12325-017-0532-9

    [12]

    NAITO Y, KASHIWAGI K, TAKAGI T, et al. Intestinal dysbiosis secondary to Proton pump inhibitor use[J]. Digestion, 2018, 97(2): 195-204. doi: 10.1159/000481813

    [13]

    ORTIZ-GUERRERO G, AMADOR-MUÑOZ D, CALDERÓN-OSPINA C A, et al. Proton pump inhibitors and dementia: physiopathological mechanisms and clinical consequences[J]. Neural Plast, 2018, 2018: 5257285.

    [14]

    TAKAHARI K, HARUMA K, OHTANI H, et al. Proton pump inhibitor induction of gastric cobblestone-like lesions in the stomach[J]. Intern Med, 2017, 56(20): 2699-2703. doi: 10.2169/internalmedicine.7964-16

    [15]

    FOSSMARK R, MARTINSEN T C, WALDUM H L. Adverse effects of proton pump inhibitors-evidence and plausibility[J]. Int J Mol Sci, 2019, 20(20): 5203. doi: 10.3390/ijms20205203

    [16] 徐致君, 陈莉丽, 杨振斌, 等. 左金加味方治疗肝胃郁热型胃食管反流病的疗效及对脑肠肽的影响[J]. 实用中医内科杂志, 2023, 37(3): 98-101. https://www.cnki.com.cn/Article/CJFDTOTAL-SYZY202303031.htm
    [17] 陈莉丽, 卜平. 不同证型胃食管反流患者脑肠肽特点[J]. 世界华人消化杂志, 2015, 23(31): 5029-5034. https://cdmd.cnki.com.cn/Article/CDMD-10600-1023120745.htm
表(5)
计量
  • 文章访问数:  0
  • HTML全文浏览量:  0
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-11-19
  • 修回日期:  2024-01-21
  • 网络出版日期:  2024-03-21
  • 刊出日期:  2024-03-14

目录

    /

    返回文章
    返回